본문 바로가기
  • Home

A Case Report of Glaucoma Improvement with Ortho-Cellular Nutrition Therapy (OCNT)

  • CELLMED
  • Abbr : CellMed
  • 2025, 15(13), pp.1~1
  • DOI : 10.5667/CellMed.spc.142
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : October 30, 2025
  • Accepted : October 31, 2025
  • Published : October 31, 2025

Yeon Choi 1

1한샘약국

Irregular Papers

ABSTRACT

Objective: Glaucoma is a chronic ophthalmic disorder characterized by impaired aqueous humor drainage, resulting in elevated intraocular pressure (IOP), optic nerve damage, and progressive visual field constriction. If untreated, it may ultimately lead to blindness. Glaucoma is classified into primary or secondary, and open-angle or angle-closure types. Conventional medical therapy focuses primarily on lowering IOP, typically through the use of topical ocular hypotensive agents. However, glaucoma frequently remains asymptomatic even after its onset. Case Report: This case involved a Korean woman in her sixties with elevated IOP who was diagnosed with glaucoma at an ophthalmology clinic. She had been treated with hospital-prescribed topical eye drops, but severe adverse effects necessitated discontinuation and the prescription of an alternative ophthalmic solution. In addition, taking the patient’s individual circumstances into account, Ortho-Cellular Nutrition Therapy (OCNT) was implemented, including anthocyanins, bilberry extract, Ginkgo biloba extract, and magnesium. Conclusion: Following the application of OCNT, the patient’s IOP decreased to 15/18 mmHg, reaching the normal range. In addition, improvements were observed in insomnia and weight loss associated with glaucoma, and the patient reported enhanced physical stamina. However, since this study was based on a single patient case, there are limitations in generalizing the findings to all glaucoma patients.

Citation status

* References for papers published after 2024 are currently being built.